Genetic Variations Associated with Drug Resistance Markers in Asymptomatic Plasmodium falciparum Infections in Myanmar
- PMID: 31505774
- PMCID: PMC6770986
- DOI: 10.3390/genes10090692
Genetic Variations Associated with Drug Resistance Markers in Asymptomatic Plasmodium falciparum Infections in Myanmar
Abstract
The emergence and spread of drug resistance is a problem hindering malaria elimination in Southeast Asia. In this study, genetic variations in drug resistance markers of Plasmodium falciparum were determined in parasites from asymptomatic populations located in three geographically dispersed townships of Myanmar by PCR and sequencing. Mutations in dihydrofolate reductase (pfdhfr), dihydropteroate synthase (pfdhps), chloroquine resistance transporter (pfcrt), multidrug resistance protein 1 (pfmdr1), multidrug resistance-associated protein 1 (pfmrp1), and Kelch protein 13 (k13) were present in 92.3%, 97.6%, 84.0%, 98.8%, and 68.3% of the parasites, respectively. The pfcrt K76T, pfmdr1 N86Y, pfmdr1 I185K, and pfmrp1 I876V mutations were present in 82.7%, 2.5%, 87.5%, and 59.8% isolates, respectively. The most prevalent haplotypes for pfdhfr, pfdhps, pfcrt and pfmdr1 were 51I/59R/108N/164L, 436A/437G/540E/581A, 74I/75E/76T/220S/271E/326N/356T/371I, and 86N/130E/184Y/185K/1225V, respectively. In addition, 57 isolates had three different point mutations (K191T, F446I, and P574L) and three types of N-terminal insertions (N, NN, NNN) in the k13 gene. In total, 43 distinct haplotypes potentially associated with multidrug resistance were identified. These findings demonstrate a high prevalence of multidrug-resistant P. falciparum in asymptomatic infections from diverse townships in Myanmar, emphasizing the importance of targeting asymptomatic infections to prevent the spread of drug-resistant P.falciparum.
Keywords: Plasmodium falciparum; asymptomatic infection; drug resistance genes; haplotypes; multidrug resistance.
Conflict of interest statement
The authors declare that they have no competing interests. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
Figures



Similar articles
-
Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).Malar J. 2017 Jan 13;16(1):28. doi: 10.1186/s12936-016-1672-0. Malar J. 2017. PMID: 28086777 Free PMC article.
-
Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.Malar J. 2011 Jan 28;10:18. doi: 10.1186/1475-2875-10-18. Malar J. 2011. PMID: 21272384 Free PMC article.
-
Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: Prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes.PLoS One. 2021 Aug 19;16(8):e0256343. doi: 10.1371/journal.pone.0256343. eCollection 2021. PLoS One. 2021. PMID: 34411157 Free PMC article.
-
Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.Malar J. 2012 Sep 19;11:333. doi: 10.1186/1475-2875-11-333. Malar J. 2012. PMID: 22992214 Free PMC article.
-
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.Curr Top Microbiol Immunol. 2005;295:39-53. doi: 10.1007/3-540-29088-5_2. Curr Top Microbiol Immunol. 2005. PMID: 16265886 Review.
Cited by
-
Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China-Myanmar border.Malar J. 2020 Aug 5;19(1):281. doi: 10.1186/s12936-020-03354-x. Malar J. 2020. PMID: 32758218 Free PMC article.
-
Using deep learning to identify recent positive selection in malaria parasite sequence data.Malar J. 2021 Jun 14;20(1):270. doi: 10.1186/s12936-021-03788-x. Malar J. 2021. PMID: 34126997 Free PMC article.
-
Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.Malar J. 2020 Aug 27;19(1):304. doi: 10.1186/s12936-020-03376-5. Malar J. 2020. PMID: 32854686 Free PMC article.
-
Advancing artemisinin resistance monitoring using a high sensitivity ddPCR assay for Pfkelch13 mutation detection in Asia.Sci Rep. 2025 Feb 10;15(1):4869. doi: 10.1038/s41598-025-86630-7. Sci Rep. 2025. PMID: 39929914 Free PMC article.
-
Multidisciplinary Investigations of Sustained Malaria Transmission in the Greater Mekong Subregion.Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):138-151. doi: 10.4269/ajtmh.21-1267. Print 2022 Oct 11. Am J Trop Med Hyg. 2022. PMID: 36228909 Free PMC article.
References
-
- WHO Strategy for Malaria Elimination in the Greater Mekong Subregion (2015–2030) [(accessed on 17 July 2019)];2015 Available online: http://iris.wpro.who.int/handle/10665.1/10945.
-
- Trape J.F. The public health impact of chloroquine resistance in Africa. [(accessed on 17 July 2019)];Am. J. Trop. Med. Hyg. 2001 64:12–17. doi: 10.4269/ajtmh.2001.64.12. Available online: http://www.ncbi.nlm.nih.gov/pubmed/11425173. - DOI - PubMed
-
- Korenromp E.L., Williams B.G., Gouws E., Dye C., Snow R.W. Measurement of trends in childhood malaria mortality in Africa: An assessment of progress toward targets based on verbal autopsy. [(accessed on 17 July 2019)];Lancet Infect. Dis. 2003 3:349–358. doi: 10.1016/S1473-3099(03)00657-1. Available online: http://www.ncbi.nlm.nih.gov/pubmed/12781507. - DOI - PubMed
-
- WHO Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000–2010. [(accessed on 17 July 2019)];2010 Available online: https://www.who.int/malaria/publications/atoz/9789241500470/en/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials